Catalyst Wire Dossier Catalyst Wire Dossier

WATCHMAN Left Atrial Appendage Closure Technology

· Boston Scientific
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WATCHMAN Left Atrial Appendage Closure Technology, covering 2015-01-27 to 2021-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology [NA]

See pricing